Scott Dahlbeck's most recent trade in Kiromic BioPharma Inc was a trade of 50,000 Common Stock done . Disclosure was reported to the exchange on Aug. 11, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiromic BioPharma Inc | Scott Dahlbeck | Chief of Staff | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 50,000 | 496,757 | - | 0 | Common Stock | |
| Kiromic BioPharma Inc | Scott Dahlbeck | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 17,240 | 446,757 | - | - | Common Stock | |
| Kiromic BioPharma Inc | Scott Dahlbeck | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 17,240 | 0 | - | - | Restricted Stock Units |